SAM
CVS icon

Storebrand Asset Management’s CVS Health CVS Stock Holding History

Storebrand Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
1,077,763
+18,380
+2% +$1.64M 0.27% 73
2026
Q1 		$76.1M Buy
1,059,383
+6,654
+0.6% +$513K 0.22% 105
2025
Q4 		$83.5M Buy
1,052,729
+15,902
+2% +$1.25M 0.22% 93
2025
Q3 		$78.2M Buy
1,036,827
+40,416
+4% +$2.77M 0.21% 101
2025
Q2 		$68.7M Buy
996,411
+7,965
+0.8% +$522K 0.2% 109
2025
Q1 		$67M Sell
988,446
-116,478
-11% -$6.97M 0.22% 101
2024
Q4 		$49.6M Buy
1,104,924
+216,180
+24% +$12.1M 0.15% 137
2024
Q3 		$55.9M Buy
888,744
+1,486
+0.2% +$86.7K 0.18% 127
2024
Q2 		$52.4M Buy
887,258
+52,430
+6% +$3.28M 0.17% 128
2024
Q1 		$66.6M Sell
834,828
-8,672
-1% -$662K 0.23% 103
2023
Q4 		$66.6M Buy
843,500
+89,307
+12% +$6.36M 0.24% 98
2023
Q3 		$52.7M Sell
754,193
-11,123
-1% -$788K 0.25% 97
2023
Q2 		$52.9M Buy
765,316
+62,771
+9% +$4.47M 0.24% 103
2023
Q1 		$52.2M Sell
702,545
-46,502
-6% -$3.9M 0.26% 99
2022
Q4 		$69.8M Sell
749,047
-16,997
-2% -$1.64M 0.39% 55
2022
Q3 		$73.1M Buy
766,044
+39,775
+5% +$3.94M 0.44% 47
2022
Q2 		$67.3M Sell
726,269
-11,758
-2% -$1.15M 0.38% 58
2022
Q1 		$74.7M Buy
738,027
+21,910
+3% +$2.3M 0.35% 65
2021
Q4 		$73.9M Buy
716,117
+19,114
+3% +$1.77M 0.33% 68
2021
Q3 		$59.1M Buy
697,003
+20,544
+3% +$1.72M 0.29% 77
2021
Q2 		$56.4M Buy
676,459
+854
+0.1% +$69.9K 0.27% 81
2021
Q1 		$50.8M Buy
675,605
+22,671
+3% +$1.65M 0.27% 81
2020
Q4 		$44.6M Buy
652,934
+105,067
+19% +$6.83M 0.26% 83
2020
Q3 		$32M Buy
547,867
+19,911
+4% +$1.24M 0.23% 97
2020
Q2 		$34.3M Buy
527,956
+18,708
+4% +$1.18M 0.28% 75
2020
Q1 		$30.2M Buy
+509,248
New +$34M 0.31% 71

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Storebrand Asset Management's CVS Position: Q2 2026 in Review

Storebrand Asset Management increased its CVS Health (CVS) stake by 1.7% in Q2 2026, buying an estimated $1.64M and bringing the position to 1,077,763 shares worth $111M. The position accounts for 0.27% of the portfolio, ranked #73.

Storebrand Asset Management first reported a position in CVS in Q1 2020 and has held it in 26 quarters since. 1,975 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Storebrand Asset Management held 1,077,763 shares of CVS Health worth $111M as of Q2 2026.
  • Storebrand Asset Management bought 18,380 CVS Health shares in Q2 2026, an estimated $1.64M.
  • CVS Health made up 0.27% of Storebrand Asset Management's portfolio in Q2 2026, its #73 holding.
  • Storebrand Asset Management first reported a position in CVS Health in Q1 2020 and has held it in 26 quarters since.
  • 1,975 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.